Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-12-01 Purchase | 2022-01-07 5:07 pm | CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer | 2,114 | $4.5273 | $9,571 | 178,473 (Direct) | View |
2021-11-01 Purchase | 2021-12-03 5:05 pm | CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer | 2,485 | $2.7375 | $6,803 | 176,359 (Direct) | View |
2021-10-01 Purchase | 2021-11-05 5:15 pm | CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer | 2,205 | $2.7205 | $5,999 | 173,874 (Direct) | View |
2021-09-01 Purchase | 2021-10-01 5:07 pm | CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer | 2,205 | $2.829 | $6,238 | 171,669 (Direct) | View |
2021-08-02 Purchase | 2021-09-10 5:03 pm | CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer | 2,205 | $2.9781 | $6,567 | 169,464 (Direct) | View |
2021-06-30 Purchase | 2021-08-13 5:10 pm | CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer | 2,310 | $3.2491 | $7,505 | 167,259 (Direct) | View |
2021-05-18 Purchase | 2021-07-09 5:10 pm | CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer | 3,150 | $3.0143 | $9,495 | 164,949 (Direct) | View |
2021-04-16 Purchase | 2021-06-08 5:22 pm | CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer | 12,985 | $2.8113 | $36,505 | 166,799 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-03-17 Other | 2022-04-29 1:11 pm | 2025-03-17 2031-03-17 | CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer | 5,000 | $0 | 178,473 (Direct) | View |
2022-03-17 Other | 2022-04-29 1:11 pm | N/A N/A | CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer | 15,000 | $2.74 | 178,473 (Direct) | View |
2021-03-17 Option Award | 2021-06-08 5:22 pm | 2025-03-17 2031-03-17 | CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer | 5,000 | $0 | 166,799 (Direct) | View |
2021-03-17 Tax Withholding | 2021-06-08 5:22 pm | N/A N/A | CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer | 2,945 | $3.22 | 166,799 (Direct) | View |
2020-03-18 Tax Withholding | 2020-04-17 5:16 pm | N/A N/A | CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer | 1,186 | $3.53 | 151,759 (Direct) | View |
2020-03-23 Option Award | 2020-04-17 5:16 pm | N/A N/A | CUMBERLAND PHARMACEUTICALS INC | CPIX | Cearnal Martin E Sr VP/Chief Commercial Officer | 5,000 | $3.56 | 151,759 (Direct) | View |